Massachusetts Financial Services’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-737,367
| Closed | -$18.8M | – | 878 |
|
|
2024
Q3 | $18.8M | Buy |
737,367
+139,104
| +23% | +$3.54M | 0.01% | 598 |
|
|
2024
Q2 | $15.2M | Buy |
598,263
+219,257
| +58% | +$5.55M | ﹤0.01% | 604 |
|
|
2024
Q1 | $11.7M | Buy |
+379,006
| New | +$11.7M | ﹤0.01% | 612 |
|
|
2021
Q4 | – | Sell |
-441,288
| Closed | -$20.7M | – | 892 |
|
|
2021
Q3 | $20.7M | Sell |
441,288
-5,844
| -1% | -$274K | 0.01% | 611 |
|
|
2021
Q2 | $27.3M | Sell |
447,132
-1,285
| -0.3% | -$78.3K | 0.01% | 582 |
|
|
2021
Q1 | $27.6M | Buy |
448,417
+25,481
| +6% | +$1.57M | 0.01% | 573 |
|
|
2020
Q4 | $30.1M | Buy |
422,936
+7,811
| +2% | +$555K | 0.01% | 546 |
|
|
2020
Q3 | $15.6M | Sell |
415,125
-10,196
| -2% | -$383K | 0.01% | 591 |
|
|
2020
Q2 | $13.9M | Buy |
425,321
+32,613
| +8% | +$1.06M | 0.01% | 582 |
|
|
2020
Q1 | $11.4M | Buy |
392,708
+78,754
| +25% | +$2.28M | 0.01% | 576 |
|
|
2019
Q4 | $11M | Buy |
313,954
+96
| +0% | +$3.37K | ﹤0.01% | 592 |
|
|
2019
Q3 | $6.74M | Sell |
313,858
-36,142
| -10% | -$776K | ﹤0.01% | 638 |
|
|
2019
Q2 | $9.44M | Buy |
+350,000
| New | +$9.44M | ﹤0.01% | 628 |
|